MedTrace Logo

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium - Maintenance

NCT07684794 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-07-06

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif XCS System when used as indicated for treatment-resistant depression (TRD).

Conditions

  • Major Depressive Disorder (MDD)

Interventions

DEVICE

Motif XCS System

The Motif XCS System is a programmable device that delivers stimulation through surface electrodes implanted in a burr hole in the skull, positioned over the left DLPFC, without penetrating the dura.

Sponsors & Collaborators

  • Motif Neurotech, Inc.

    lead INDUSTRY

Principal Investigators

  • Esther Elliott · Alithia Life Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-10
Primary Completion
2026-11-01
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07684794 on ClinicalTrials.gov